Accessibility Menu
Medartis Ag logo

Medartis Ag(XSWX) MED

Market CapCHF 1.15BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)+48%
5 Year-30%
1 Year-3%
1 Month+1%
CHF 89.10
-3.15%
-2.90Today
Medartis Ag last closing stock price
MetricPriceDate
Last closeCHF 88.702026-08-31
Medartis Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.8%CHF 88.002026-08-24
1 month+1.03%CHF 87.802026-07-31
3 month+22.18%CHF 72.602026-06-02
Year to date+0.57%CHF 88.202025-12-30
1 year-2.53%CHF 91.002025-08-29
3 year+0.23%CHF 88.502023-09-01
5 year-29.71%CHF 126.202021-09-01
Since inception+48.48%CHF 61.962018-03-23

Medartis Ag Financials at a Glance

Market Cap

CHF 1.15BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$316.93M

Net Income (TTM)

-$25.60M

EPS (TTM)

CHF 1.20

P/E Ratio

76.66

Dividend

CHF 0.00

Beta (Volatility)

0.08 (Low)

Price

CHF 89.10

Volume

3,524

Open

CHF 94.00

Previous Close

CHF 92.00

Daily Range

CHF 88.20 - CHF 94.00

52-Week Range

CHF 70.60 - CHF 97.50

Estimated Earnings Date

Nov 9, 2026

MED News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medartis Ag

Medifast, Inc. is a leading provider of health and nutritional products focused on weight loss, weight management, and overall wellness. Established in 1980 and headquartered in Baltimore, Maryland, the company offers a diverse range of consumable items marketed under well-known brands such as OPTAVIA and Optimal Health.

Products and Services
  • Wide range of health and nutritional products including snack bars and shakes
  • Meal replacement options designed for weight management
  • Direct e-commerce sales model for customer convenience
Growth Outlook
  • Revenue of $76.38 million in Q2 2026, showing stability
  • Gross profit margin of 69.9% indicates strong product demand
  • Current ratio of 4.86 suggests robust liquidity position
Financial Highlights
  • Net income of -$3.1 million in Q2 2026, reflecting ongoing challenges
  • Cash and short-term investments total $169.82 million, providing financial flexibility
  • Debt ratio of 10.61% indicates low leverage and financial risk
Medifast, Inc. operates in the personal products and services sector, focusing on health and wellness. The company has established a strong market presence through its innovative product offerings and direct-to-consumer sales approach. Despite facing recent financial challenges, the company maintains a solid liquidity position, which may support future growth initiatives. The gross profit margin remains high, indicating that the products are well-received in the market. Investors may find the company's focus on health and wellness appealing, especially as consumer interest in these areas continues to grow.
AI Generated • Aug 22, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

1,337

CEO

Matthias Schupp

Website

www.medartis.com

Headquarters

Baltimore, MD 21224, US

MED Financials

Key Financial Metrics (TTM)

Gross Margin

69.24%

Operating Margin

-5.46%

Net Income Margin

-8.08%

Return on Equity

-12.68%

Return on Capital

-6.59%

Return on Assets

-9.83%

Earnings Yield

1.30%

Dividend Yield

0.00%

Payout Ratio

-0.66%

Stock Overview

Market Cap

CHF 1.15BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.45M

Volume

3.52K

Avg. Volume

5.93K

Financials (TTM)

Gross Profit

$219.45M

Operating Income

-$17.31M

EBITDA

-$3.57M

Operating Cash Flow

$8.79M

Capital Expenditure

-$4.78M

Free Cash Flow

$4.01M

Cash & ST Invst.

$169.82M

Total Debt

$27.62M

Medartis Ag Performance Analysis

Medartis Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 182,824,41814.4%
20232023-12-31USD 212,006,00016.0%
20242024-12-31USD 224,831,0006.0%
20252025-12-31USD 269,257,00019.8%
Medartis Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-15.3%
Q42025-12-31-16.0%
Q12026-03-311.3%
Q22026-06-300.4%
Medartis Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.49N/A
20232023-12-31USD 0.05N/A
20242024-12-31USD 0.28462.1%
20252025-12-31USD 0.67135.9%
Medartis Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-195.5%
Q42025-12-31-685.7%
Q12026-03-3188.5%
Q22026-06-30-47.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$76.38M

-27.6%

Gross Profit

$53.40M

-30.3%

Gross Margin

69.90%

N/A

Market Cap

CHF 1.15BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CHF 3.01M

N/A

Employees

380

N/A

Net Income

-$3.10M

-225.0%

EBITDA

-$2.99M

-143.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$169.82M

+4.4%

Total Debt

$27.62M

+111.3%

Accounts Receivable

$0.00

N/A

Inventory

$21.18M

-29.9%

Long Term Debt

$22.46M

+214.4%

Short Term Debt

$5.16M

-12.9%

Return on Assets

-9.83%

N/A

Return on Invested Capital

-7.91%

N/A

Free Cash Flow

$728.00K

+115.3%

Operating Cash Flow

$1.70M

+150.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CURVTorrid Holdings Inc.
$2.20-3.51%
CAASChina Automotive Systems, Inc.
$5.51+10.42%
BSETBassett Furniture Industries, Incorporated
$18.80+0.35%
DIBS1stdibs.com, Inc.
$4.37-2.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About MED

What is the current price of Medartis Ag?

Medartis Ag is trading at CHF 89.10 per share.

What is the 52-week range for Medartis Ag?

Over the past 52 weeks, Medartis Ag has traded between CHF 70.60 and CHF 97.50.

How much debt does Medartis Ag have?

As of the most recent reporting period, Medartis Ag reported total debt of $158.12M.

How much cash does Medartis Ag have on hand?

Medartis Ag reported $32.97M in cash and cash equivalents in its most recent financial results.

What is Medartis Ag’s dividend yield?

Medartis Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services